Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Medical tech supplier Novanta sets 2026 growth outlook after Q4 sales rise

Summary by stocktitan.net
Q4 bookings climbed 25% as Novanta posted $980.6M revenue, 2025 adjusted EPS of $3.29, and 2026 guidance for $1.03B–$1.05B sales and $3.50–$3.65 EPS.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

stocktitan.netstocktitan.net

Medical tech supplier Novanta sets 2026 growth outlook after Q4 sales rise

Q4 bookings climbed 25% as Novanta posted $980.6M revenue, 2025 adjusted EPS of $3.29, and 2026 guidance for $1.03B–$1.05B sales and $3.50–$3.65 EPS.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Monday, February 23, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Bedford, Massachusetts icon

Bedford, Massachusetts

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal